Results 161 to 170 of about 421,104 (286)

Heritage and practices of public formation [PDF]

, 2010
Arendt H., Bauman Z., Benjamin A., Hall S., Harrison R., Roger I. Simon, Susan L.T. Ashley, Warner M.   +7 more
core   +2 more sources

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Envisioning grassroots science: DIY biology in Canada, Britain, and Germany. [PDF]

PLoS One
Eireiner AV.
europepmc   +1 more source

PUBLICITY/PUBLICATION

, 2021
openaire   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

Editorial: Inclusive health communication: strategies for equitable information dissemination. [PDF]

Front Public Health
Munté-Pascual A, Ruiz-Eugenio L.
europepmc   +1 more source

Publicity [PDF]

British Journal of Ophthalmology, 1935
openaire   +2 more sources

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

L’étude des prestataires dans les transformations des musées. L’exemple des offres numériques

Culture & Musées, 2023
Noémie Couillard
doaj   +1 more source

Selfhood and inclusive publics: a critical disability lens and creative practice to ground collaborative homelessness research. [PDF]

Front Sociol
Middelmann T.
europepmc   +1 more source